Rigel Pharmaceuticals Inc. (New) RIGL
$42.45
-0.31%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (3 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $59.00
- Implied Upside
- +39.0%
- Price Target Range
- $38.00 – $85.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-17 | Piper SandlerAllison Bratzel |
Maintains | Neutral | $40 → $49 |
| 2026-08-14 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $57 → $85 |
| 2026-06-02 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $57 |
| 2026-05-27 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $57 |
| 2026-05-22 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $57 |
| 2026-05-13 | CitigroupYigal Nochomovitz |
Maintains | Buy | $69 → $81 |
| 2026-05-07 | CitigroupYigal Nochomovitz |
Maintains | Buy | $71 → $69 |
| 2025-11-05 | JefferiesEun Yang |
Upgrades | Hold → Buy | $23 → $42 |
| 2025-11-05 | Cantor FitzgeraldKristen Kluska |
Maintains | Neutral | $32 → $38 |
| 2025-10-08 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $57 |
| 2025-08-06 | Cantor FitzgeraldKristen Kluska |
Maintains | Neutral | $23 → $32 |
| 2025-05-07 | Cantor FitzgeraldKristen Kluska |
Maintains | Neutral | $20 → $23 |
| 2025-03-06 | CitigroupYigal Nochomovitz |
Maintains | Buy | $49 → $55 |
| 2025-03-05 | B. Riley SecuritiesKalpit Patel |
Maintains | Neutral | $20 → $24 |
| 2025-03-05 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $57 |
| 2025-01-23 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $57 |
| 2025-01-14 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $57 |
| 2024-12-10 | Cantor FitzgeraldKristen Kluska |
Maintains | Neutral | $15 → $25 |
| 2024-12-10 | B. Riley SecuritiesKalpit Patel |
Maintains | Neutral | $27 → $20 |
| 2024-12-10 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $57 |
| 2024-12-06 | B. Riley SecuritiesKalpit Patel |
Maintains | Neutral | $17 → $27 |
| 2024-11-14 | Piper SandlerAllison Bratzel |
Maintains | Neutral | $15 → $23 |
| 2024-11-12 | CitigroupYigal Nochomovitz |
Maintains | Buy | $40 → $49 |
| 2024-10-25 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $57 |
| 2024-09-20 | Cantor FitzgeraldKristen Kluska |
Reiterates | Neutral | $15 |
| 2024-09-05 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $57 |
| 2024-09-03 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $57 |
| 2024-08-09 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $15 → $57 |
| 2024-06-25 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $150 |
| 2024-06-17 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $150 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $42.45
- Market Cap
- $795.39 million
- 52-Week Range
- $18.65 – $52.24
- Average Volume
- 338K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.